Brigit Biofarmaka Teknologi Tbk. vs Cerestar Indonesia Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Cerestar Indonesia Tbk. trades at Rp165 (market cap 1.3T, 76.5K 24h volume). The key difference: Cerestar Indonesia Tbk. is far larger — about 7.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 76.5K). Which is the better fit depends on your goals.
| OBAT | TRGU | |
|---|---|---|
Market Cap | 172.82B | 1.3T |
Volume | 592.2K | 76.5K |
Lot | 5.92K | 765 |
Turnover | 147.05M | 12.41M |
Average Price | 248.31 | 162.16 |
Value | 147.05M | 12.41M |
Indicative Equilibrium Price | 254 | — |
Indicative Equilibrium Volume | 10 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT. Cerestar Indonesia Tbk (the Company) was established based on Notarial Deed No. 2 datedAugust 30, 2020 of Dwi Yulianti, S.H., notary in Jakarta The Company started its commercial operations in 2021.
Read more on TRGU →